
Ben Caballero breaks his own world record for annual home sales
Ben Caballero breaks his own world record for annual home sales by Emily Marek May 2, 2024 Ben Caballero, CEO and founder of HomesUSA, set a
Ben Caballero breaks his own world record for annual home sales by Emily Marek May 2, 2024 Ben Caballero, CEO and founder of HomesUSA, set a
Economic headwinds holding back seasonal new-home sales in Austin market, expert says. by Shonda Novak April 22, 2024 This just in from Ben Caballero, a
HomesUSA: Spring ‘rebound’ incoming for Texas new-home sales by Emily Marek February 22, 2024 New-home sales decreased across Texas last month, according to the
Special guest post by Terri Hayley, “New Home Sales Whisperer” With four to five million home sales every year, listings and features may often seem
May 5th, 2022 – The Houston Chronicle – If you needed more of an indication on how wild the Texas housing market was during the
Ben Caballero, founder and CEO of HomeUSA.com is known as a real estate legend and phenomena. Throughout last year, he led the development of SpecDeck,
In 2023, HomesUSA.com launched SpecDeck, its cutting-edge technology that empowers builders to replace their in-house MLS listing process. SpecDeck uses strategic automation to create
Ben Caballero, the founder and CEO of HomesUSA.com, is known for revolutionizing how new homes are marketed. His unique approach to real estate, deeply ingrained
Ben Caballero broke records for selling 16 homes a day and becoming the first individual agent to sell $1 billion and $2 billion of houses
December 18, 2022 – WAV Group – Kevin Hawkins For almost a decade, we have been working with Ben Caballero, the No. 1-ranked real estate
HomesUSA.com reports new homes are selling faster as average price falls DALLAS, Dec. 21, 2023 (GLOBE NEWSWIRE) — Texas new home sales remained steady last
For Houston’s top residential brokers, 2023 saw a great divide. Top performers stood out more than ever in a year largely defined by residential decline.
Equal Housing Opportunity
Formulary
We’ll be happy to send you this document! Please fill out the following contact form, and we’ll reach out to you with the appropriate information.